ArticleJournal of intensive care2023

Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study.

Matsuyuki Doi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.